Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
CONy 2023
ACTRIMS 2023
ISC 2023
EHC 2022
AES 2022
WSC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Stewart Tepper
2:05
AHS highlights: atogepant and zavegepant for migraine treatment
Stewart Tepper
• 17 Jun 2022
4:17
Assessing the efficacy of fremanezumab on interictal migraine related burden
Stewart Tepper
• 17 Jun 2022
2:00
Discontinuation of anti-CGRP antibodies in non-responders
Stewart Tepper
• 17 Jun 2022
5:55
Increased placebo response over time in migraine preventive trials
Stewart Tepper
• 17 Jun 2022
11:31
Therapeutic landscape for cluster headache
Stewart Tepper
• 24 May 2020
20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper
• 24 May 2020
19:11
Benefit of migraine prevention with erenumab
Stewart Tepper
• 24 May 2020
9:29
CONQUER: galcanezumab in treatment-resistant migraine
Stewart Tepper
• 24 May 2020
7:37
Erenumab in migraine with or without aura: cardiovascular safety
Stewart Tepper
• 24 May 2020
